About AxoGen, Inc.
https://www.axogeninc.comAxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves.
CEO
Michael D. Dale
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 1994-07-11 | Forward | 21:20 |
| 1993-07-12 | Forward | 21:20 |
ETFs Holding This Stock
Summary
Showing Top 3 of 113
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
Canaccord Genuity
Buy
HC Wainwright & Co.
Buy
Jefferies
Buy
Lake Street
Buy
Citizens
Market Outperform
Citizens Capital Markets
Market Outperform
Grade Summary
Showing Top 6 of 8
Price Target
Institutional Ownership
FIRST LIGHT ASSET MANAGEMENT, LLC
Shares:5.81M
Value:$178.82M
BLACKROCK, INC.
Shares:3.61M
Value:$111.16M
BLACKROCK INC.
Shares:3.25M
Value:$100.08M
Summary
Showing Top 3 of 219
About AxoGen, Inc.
https://www.axogeninc.comAxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $60.08M ▲ | $44.08M ▲ | $708K ▲ | 1.18% ▲ | $0.02 ▲ | $12.65M ▲ |
| Q2-2025 | $56.66M ▲ | $40.35M ▲ | $579K ▲ | 1.02% ▲ | $0.01 ▲ | $4.38M ▲ |
| Q1-2025 | $48.56M ▼ | $36.59M ▲ | $-3.83M ▼ | -7.9% ▼ | $-0.08 ▼ | $298K ▼ |
| Q4-2024 | $49.41M ▲ | $35.56M ▼ | $450K ▲ | 0.91% ▲ | $0.01 ▲ | $4.17M ▲ |
| Q3-2024 | $48.64M | $36.75M | $-1.86M | -3.82% | $-0.04 | $2M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $35.79M ▼ | $216.4M ▲ | $95.59M ▲ | $120.81M ▲ |
| Q2-2025 | $35.92M ▲ | $205.45M ▲ | $93.18M ▲ | $112.28M ▲ |
| Q1-2025 | $22.07M ▼ | $196.16M ▼ | $90.8M ▼ | $105.36M ▲ |
| Q4-2024 | $33.48M ▲ | $203.73M ▲ | $99.82M ▲ | $103.91M ▲ |
| Q3-2024 | $24.53M | $191.99M | $92.58M | $99.41M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $708K ▲ | $3.22M ▼ | $-3.75M ▲ | $2.39M ▲ | $1.87M ▼ | $1.36M ▼ |
| Q2-2025 | $579K ▲ | $7.73M ▲ | $-6.95M ▼ | $1.16M ▼ | $1.94M ▲ | $7.01M ▲ |
| Q1-2025 | $-3.83M ▼ | $-13.18M ▼ | $1.34M ▲ | $2.38M ▲ | $-9.46M ▼ | $-13.44M ▼ |
| Q4-2024 | $450K ▲ | $8.73M ▲ | $-813K ▲ | $970K ▲ | $8.89M ▲ | $7.92M ▲ |
| Q3-2024 | $-1.86M | $3.9M | $-5M | $572K | $-527K | $2.76M |
CEO
Michael D. Dale
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 1994-07-11 | Forward | 21:20 |
| 1993-07-12 | Forward | 21:20 |
ETFs Holding This Stock
Summary
Showing Top 3 of 113
Ratings Snapshot
Rating : C-
Most Recent Analyst Grades
Canaccord Genuity
Buy
HC Wainwright & Co.
Buy
Jefferies
Buy
Lake Street
Buy
Citizens
Market Outperform
Citizens Capital Markets
Market Outperform
Grade Summary
Showing Top 6 of 8
Price Target
Institutional Ownership
FIRST LIGHT ASSET MANAGEMENT, LLC
Shares:5.81M
Value:$178.82M
BLACKROCK, INC.
Shares:3.61M
Value:$111.16M
BLACKROCK INC.
Shares:3.25M
Value:$100.08M
Summary
Showing Top 3 of 219